CD5: A safeguard against autoimmunity and a shield for cancer cells
Author:
- 1 February 2009
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 8 (4) , 349-353
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Regulatory B cells as inhibitors of immune responses and inflammationImmunological Reviews, 2008
- Upon TLR9 Signaling, CD5+ B Cells Control the IL-12-Dependent Th1-Priming Capacity of Neonatal DCsImmunity, 2005
- Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 productionBlood, 2002
- B cells regulate autoimmunity by provision of IL-10Nature Immunology, 2002
- CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40Immunology, 2000
- A Role for CD5 in TCR-Mediated Signal Transduction and Thymocyte SelectionScience, 1995
- Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycinInternational Immunology, 1995
- Expression and regulation of CD5 on in vitro activated human B cellsEuropean Journal of Immunology, 1989
- B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.Journal of Clinical Investigation, 1987
- An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.Journal of Experimental Medicine, 1980